Allosteric modulation of the dopamine receptor by conformationally constrained type VI β-turn peptidomimetics of Pro-Leu-Gly-NH2

Journal of Medicinal Chemistry

Volumn 50, Issue 26, 2007, Pages 6725-6729

  Vartak, Ashish P ^a   Skoblenick, Kevin ^b   Thomas, Nancy ^b   Mishra, Ram K ^b   Johnson, Rodney L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYL COMPOUND; BICYCLO COMPOUND; DOPAMINE RECEPTOR; INDOLIZIDINE DERIVATIVE; NORAPOMORPHINE; PROLINE DERIVATIVE; PROLYLLEUCYLGLYCINAMIDE; PROLYLLEUCYLPROLINAMIDE; PROLYLPROLYLPROLINAMIDE; SPIRO COMPOUND; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; CHIRALITY; COW; DRUG BINDING SITE; DRUG CONFORMATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HYDROGEN BOND; NONHUMAN; QUANTUM YIELD; REACTION ANALYSIS;

ALLOSTERIC REGULATION; BICYCLO COMPOUNDS, HETEROCYCLIC; INDOLIZIDINES; MODELS, MOLECULAR; MOLECULAR MIMICRY; MSH RELEASE-INHIBITING HORMONE; PROLINE; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, DOPAMINE; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 37349031106     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070895r     Document Type: Article

References (29)

1. Smith, J. R.; Morgan, M. The Effects of PLG on Drug Induced Rotation in Rats. Gen. Pharmacol. 1982, 13, 203-207.
2. Ott, M. C.; Mishra, R. K.; Johnson, R. L. Modulation of Dopaminergic Neurotransmission in the 6-Hydroxydopamine Lesioned Rotational Model by Peptidomimetic Analogues of L-Prolyl-L-leucyl-glycinamide. Brain Res. 1996, 737, 287-291.
3. 2 (PLG). Peptides 1997, 18, 1209-1217.
4. Fisher, A.; Mann, A.; Verma, V.; Thomas, N.; Mishra, R. K.; Johnson, R. L. Design and Synthesis of Photoaffinity-Labeling Ligands of the L-Prolyl-L-leucylglycinamide Binding Site Involved in the Allosteric Modulation of the Dopamine Receptor. J. Med. Chem. 2006, 49, 307-317.
5. 2 Receptor: Evidence for Modulation of Agonist Affinity States in Bovine Striatal Membranes. J. Neurochem. 1988, 50, 960-967.
6. 2 Receptor by L-Pro-L- Leu-glycinamide (PLG) Analogue 3(R)-(N-L-Prolylamino)-2- oxo-1-pyrrolidineacetamide. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 1990, 14, 821-827.
7. Verma, V.; Mann, A.; Costain, W.; Pontoriero, G.; Castellano, J. M.; Skoblenick, K.; Gupta, S. K.; Pristupa, Z.; Niznik, H. B.; Johnson, R. L.; Nair, V. D.; Mishra, R. K. Modulation of Agonist Binding to Human Dopamine Receptor Subtypes by L-Prolyl-L-Leucyl-glycinamide and a Peptidomimetic Analogue. J. Pharmacol. Exp. Ther. 2005, 3151228-1236.
8. A Receptor. Brain Res. Bull. 1990, 25, 917-919.
9. Gulati, A.; Bhargava, H. N. Effect of Melanotropin Release Inhibiting Factor on Changes by Haloperidol and Centbutindole in Cerebral Cortical 5-Hydroxytryptamine Receptors. Pharmacology 1990, 41, 98-106.
10. 2. J. Med. Chem. 1988, 31, 1430-1436.
11. 2. J. Med. Chem. 1993, 36, 256-263.
12. 2. J. Med. Chem. 1993, 36, 2356-2361.
13. 2. J. Med. Chem. 1993, 36, 3481-3483.
14. Khalil, E. M.; Ojala, W. H.; Pradhan, A.; Nair, V. D.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Design, Synthesis, and Dopamine Receptor Modulating Activity of Spiro Bicyclic Peptidomimetics of L-Prolyl- L-leucyl-glycinamide. J. Med. Chem. 1999, 42, 628-637.
15. 2 Analogues Possessing Cyclic Amino Acid Residues at the C-Terminal Position. J. Med. Chem. 1986, 29, 2100-2104.
16. Baures, P. W.; Pradhan, A.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Synthesis and Dopamine Receptor Modulating Activity of Unsubstituted and Substituted Triproline Analogues of L-Prolyl- L-leucyl-glycinamide. Bioorg. Med. Chem. Lett. 1999, 9, 2349-2352.
17. (a) Yao, J.; Victoria, A.; Feher, B.; Fabiola, E.; Reymond, M. T.; Wright, P. E.; Dyson, J. H. Stabilization of a Type-VI Turn in a Family of Linear Peptides in Water Solution. J. Mol. Biol. 1994, 243, 736-753.
18. (b) Richardson, J. S.; Richardson, D. C. Prediction of Protein Structure and the Principles of Protein Conformation; Fasman, G. D., Ed.; Plenum-Press: New York, 1989; pp 48-53.
19. Kim, K.; Dumas, J.; Germanas, J. P. Novel Bicyclic Lactams as XaaPro Type VI β-Turn Mimics: Design, Synthesis and Evaluation. J. Org. Chem. 1996, 61, 3138-3144.
20. Seebach, D.; Boes, M.; Naef, R.; Schweizer, W. B. Alkylation of Amino Acids without Loss of the Optical Activity: Preparation of α-Substituted Proline Derivatives. A Case of Self-Reproduction of Chirality. J. Am. Chem. Soc. 1983, 105, 5390-5398.
21. Gramberg, D.; Weber, C.; Beeli, R.; Inglis, J.; Bruns, C.; Robinson, J. A. Synthesis of a Type-VI β-Turn Peptide Mimetic and Its Incorporation into a High-Affinity Somatostatin Receptor Ligand. Helv. Chim. Acta 1995, 78, 1588-1606.
22. Khalil, E. M.; Subasinghe, N. L.; Johnson, R. L. An Efficient and High Yield Method for the N-tert-Butoxycarbonyl Protection of Sterically Hindered Amino Acids. Tetrahedron Lett. 1996, 37, 3441-3444.
23. Ku, B.; Oh, D. Y. Facile Synthesis of α-Phophorylated α-Amino Acids. Tetrahedron Lett. 1998, 29, 4465-4466.
24. Kober, R.; Steglich, W. Reaction of Acylaminobromomalonates and Acylaminobromoacetates with Trialkyl Phosphates. A Simple Synthesis of Ethyl 2-Amino-2-(diethoxyphosphoryl)acetate. Liebigs Ann. Chim. 1983, 4, 599-609.
25. Zhang, J.; Xiong, C.; Ying, J.; Wang, W.; Hruby, V. J. Stereoselective Synthesis of Novel Dipeptide β-Turn Mimetics Targeting Melanocortin Peptide Receptors. Org. Lett. 2003, 5, 3115-3118.
26. 2. Org. Lett. 2006, 8, 983-986.
27. Dolbeare, K.; Pontoriero, G. F.; Gupta, S. K.; Mishra, R. K.; Johnson, R. L. Synthesis and Dopamine Receptor Modulating Activity of 3-Substituted γ-Lactam Peptidomimetics of L-Prolyl-L-leucyl- glycinamide. J. Med. Chem. 2003, 46, 727-733.
28. 2 Modified at the Leucyl Residue. J. Med. Chem. 1990, 33, 1828-1832.
29. Khalil, E. M.; Pradhan, A.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Synthesis and Dopamine Receptor Modulating Activity of Substituted Bicyclic Thiazolidine Lactam Peptidomimetics of L-Prolyl- L-leucyl-glycinamide. J. Med. Chem. 1999, 42, 2977-2987.